Primary biliary cholangitis
Do you want to receive a message when there is new research about Primary Biliary Cholangitis? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, above each publication you'll find one sentence explaining what was studied — and you'll receive a message as soon as there is new research about Primary Biliary Cholangitis. View what Premium costs.
Publications (1515)
- Commentary or editorialiAn expert's opinion or commentary, not new research. Primary biliary cholangitis, Celiac Disease, and MASLD: the triumvirate of steatosis. How should we manage this triple overlap? (2025/02/01) ♡
- Treatment guidelineiAn official agreement between doctors about how this disease should be treated. This is not a single study but the conclusion of an entire medical field. Primary sclerosing cholangitis in children with inflammatory bowel disease: An ESPGHAN position paper from the Hepatology Committee and the IBD Porto group. (2025/02/01) ♡
- Obeticholic acid aggravates liver fibrosis by activating hepatic farnesoid X receptor-induced apoptosis in cholestatic mice. (2025/01/25) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Intestinal obstruction caused by disseminated mycobacterium avium complex disease following solid organ transplantation: a case report. (2025/01/25) ♡
- [Gastroenterology and hepatology : what's new in 2024]. (2025/01/22) ♡
- Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Mendelian randomization studies of risk and protective factors for osteoporosis: a systematic review and meta-analysis. (2025/01/16) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The Role of Sulfatides in Liver Health and Disease. (2025/01/16) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Latest FDA approved drug Elafibranor (Iqirvo): a novel prospect for treatment of primary biliary cholangitis. (2025/01/09) ♡
- Antibodies directed against bacterial antigens in sera of Polish patients with primary biliary cholangitis. (2025/01/07) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The utilisation of biliary organoids for biomedical applications. (2025/01/07) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Gun-Sight Technique With Dual Hepatic Vascular Embolization for Sigmoidal Refractory Biliary Stricture After Living-Donor Liver Transplantation: A Case Report. (2025/01/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Utility of Mac-2 binding protein glycosylation isomer as an excellent biomarker for the prediction of liver fibrosis, activity, and hepatocellular carcinoma onset: an expert review. (2025/01/01) ♡
- A heterogeneous subtype of biliary epithelial senescence may be involved in the pathogenesis of primary biliary cholangitis. (2025/01/01) ♡
- Sarcopenia is associated with new-onset acute biliary infection within 1 year in patients with hepatitis B virus-related decompensated cirrhosis. (2025/01/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. The association of human milk intake and outcomes in biliary atresia. (2025/01/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Considerations in the development of the International Multicenter Pediatric Portal Hypertension Registry. (2025/01/01) ♡
- Quantitative detection of anti-centromere antibodies in primary biliary cholangitis: value of chemiluminescence immunoassay. (2025/01/01) ♡
- FTO-mediated regulation of Kupffer cell polarization and interleukin-6 secretion promotes biliary epithelial cell proliferation in intrahepatic bile duct stones. (2024/12/31) ♡
- Impact of major duodenal papilla morphology on the outcomes of primary needle-knife fistulotomy for deep biliary cannulation. (2024/12/30) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Primary Biliary Cholangitis Associated with Ulcerative Colitis: Case Series and Literature Review. (2024/12/30) ♡
- The mediating role of primary sclerosising cholangitis in the association between ulcerative colitis and hepatobiliary cancer investigated through Mendelian randomization. (2024/12/28) ♡
- Development and external validation of an early prediction model to identify irresponsive patients and prognosis of UDCA treatment in primary biliary cholangitis. (2024/12/28) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. A rare case of postoperative hemorrhage following laparoscopic cholecystectomy - A case report. (2024/12/28) ♡
- Clinical analysis of Klebsiella pneumoniae infection in patients with liver cirrhosis in Beijing. (2024/12/27) ♡
- External validation of EncephalApp Stroop test to screen minimal hepatic encephalopathy patients with nonalcoholic cirrhosis. (2024/12/27) ♡
- A new diagnosis of primary biliary cholangitis in pregnancy treated with a combination of ursodeoxycholic acid and bezafibrate. (2024/12/25) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Hepatic angiosarcoma in a patient treated with obeticholic acid for primary biliary cholangitis. (2024/12/24) ♡
- Elafibranor (Iqirvo) for primary biliary cholangitis. (2024/12/23) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. AI in Hepatology: Revolutionizing the Diagnosis and Management of Liver Disease. (2024/12/22) ♡
- Probing the Effects of Multisite Mutations in the Lipoic Acid Region of the BCOADC-E2 Protein. (2024/12/21) ♡
- Assessment of Non-alcoholic Fatty Liver Disease and Level of Risk of Fibrosis in Diabetic and Non-diabetic Individuals. (2024/12/21) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. PPAR agonists for the treatment of cholestatic liver diseases: Over a decade of clinical progress. (2024/12/20) ♡
- Antiplatelet Prophylaxis Reduces the Risk of Early Hepatic Artery Thrombosis Following Liver Transplantation in High-Risk Patients. (2024/12/18) ♡
- Genetically predicted immune cells mediate the association between gut microbiota and autoimmune liver diseases. (2024/12/16) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Fibrillary Glomerulonephritis in a Patient With Sjögren's Syndrome and Primary Biliary Cholangitis: A Case Report and Literature Review. (2024/12/14) ♡
- The Differential Complement, Fc and Chemokine Receptor Expression of B Cells in IgG4-Related Pancreatobiliary Disease and Primary Sclerosising Cholangitis and Its Relevance for Targeting B Cell Pathways in Disease. (2024/12/13) ♡
- Transaneurysmal Suturing of Pseudoaneurysm Neck: Novel and Not a Pseudo-Technique for Treatment of Complicated Femoral Pseudoaneurysm. (2024/12/11) ♡
- Quantitative fibrosis identifies biliary tract involvement and is associated with outcomes in pediatric autoimmune liver disease. (2024/12/11) ♡
- Placental growth factor modulates endothelial NO production and exacerbates experimental hepatopulmonary syndrome. (2024/12/10) ♡
- Cytoskeleton Remodeling-Related Proteins Represent a Specific Salivary Signature in PSC Patients. (2024/12/07) ♡
- Mean liver density independently predicts therapeutic response and liver-related mortality in patients with primary biliary cholangitis. (2024/12/05) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Molecular Mechanisms of Fibrosis in Cholestatic Liver Diseases and Regenerative Medicine-Based Therapies. (2024/12/03) ♡
- Is an 8 mm cutoff necessary when performing primary common bile duct closure after laparoscopic common bile duct exploration? (2024/12/01) ♡
- Impact of Clinical Characteristics and Treatment on Cholangiocarcinoma Prognosis in Southern Thailand. (2024/12/01) ♡
- Percutaneous Transhepatic Cholangioscopy in Hepatolithiasis Associated With Decompensated Cirrhosis: A Retrospective Cohort Study. (2024/12/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Revisiting septic shock in cirrhosis: a call for personalized management. (2024/12/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Predicting and managing liver fibrosis in biliary atresia. (2024/12/01) ♡
- Disparities in Primary Biliary Cholangitis: A Retrospective Study Using Real-World Data From a Single Hepatology Clinic in the Greater Los Angeles Area. (2024/12/01) ♡
- Elafibranor Long-Term Efficacy and Safety and Impact on Fatigue in Primary Biliary Cholangitis: Interim Results From the Open-Label Extension of the ELATIVE Trial Up to 3 Years. (2024/12/01) ♡
- Efficacy and Safety of Seladelpar in Patients With Primary Biliary Cholangitis and Compensated Cirrhosis in the Phase 3 Placebo-Controlled RESPONSE Trial. (2024/12/01) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.